China Pharma Holdings (CPHI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2001 | 12-2000 | |
| Cash Flows From Operating Activities | ||
| Net Income | -398 | N/A |
| Depreciation Amortization | 82 | N/A |
| Accounts payable and accrued liabilities | -12 | N/A |
| Other Working Capital | -19 | N/A |
| Other Operating Activity | 24 | 0 |
| Operating Cash Flow | $-323 | $N/A |
| Cash Flows From Investing Activities | ||
| PPE Investments | -31 | N/A |
| Investing Cash Flow | $-32 | $N/A |
| Cash Flows From Financing Activities | ||
| Debt Issued | 75 | N/A |
| Debt Repayment | -131 | N/A |
| Common Stock Issued | 416 | N/A |
| Financing Cash Flow | $360 | $N/A |
| Beginning Cash Position | 8 | N/A |
| End Cash Position | 13 | N/A |
| Net Cash Flow | $5 | $N/A |
| Free Cash Flow | ||
| Operating Cash Flow | -323 | N/A |
| Capital Expenditure | -31 | N/A |
| Free Cash Flow | -355 | 0 |